NCT00341549

Brief Summary

This study will try to identify the gene or genes responsible for myopia (nearsightedness) and to examine the relationship between myopia and near work. Myopia is the most common eye disorder in the world, affecting one in four Americans. Several studies indicate that myopia is inherited. The condition tends to cluster in families, so that studying families with this condition may facilitate finding the exact cause. Caucasian Americans and African Americans with myopia who are in general good health may be eligible for this study. People with a family history of myopia through several generations along one parent s side only, and in which more than one sibling has myopia are preferred. People who have severe diseases that involve myopia, such as Stickler s or Marfan syndromes, retinitis pigmentosa or diabetic retinopathy may not participate. Participants will undergo the following tests and procedures:

  • Eye examination, including refraction
  • Blood draw for genetic studies and possibly establishment of cell lines (collection of cells grown in the laboratory from an original tissue specimen) for future research
  • Myopia Family Study Questionnaire and personal medical information questionnaire to provide information about other medical conditions that may influence the development of myopia; the vision status of their spouse and children, parents and siblings, and spouse s parents and siblings
  • Risk Factor Questionnaire (for Jewish Orthodox community only) to assess the amount of near work activity done in childhood

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,477

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2002

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

June 19, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 21, 2006

Completed
13.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2020

Completed
Last Updated

March 13, 2020

Status Verified

March 1, 2020

Enrollment Period

17.9 years

First QC Date

June 19, 2006

Last Update Submit

March 12, 2020

Conditions

Keywords

GeneticsMappingGeneMyopiaNearsightedness

Outcome Measures

Primary Outcomes (1)

  • Myopia Genes

    The overall objective for this project is to query the entire human genome to identify the genes responsible for myopia and for variation in ocular refraction.

    Ongoing

Study Arms (1)

Myopia

The subject population will be adult individuals and their children, in good health with the exception of myopia.

Eligibility Criteria

Age1 Month+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The subject population will be adult individuals and their children, in good health with the exception of myopia.@@@@@@

You may qualify if:

  • The subject population will be adult individuals and their children, in good health with the exception of myopia.
  • Subjects will be chosen based upon vision history of their extended family.
  • Preferred subjects will be those who have a family in which myopia passes through several generations along one parent s side only, in which more than one sibling is affected with myopia, but in which no more than one parent is affected.
  • Specific eligibility requirements for the index case include:
  • Cycloplegic refraction of 1.00 spherical equivalent (as long as there was 1.00D or higher in each meridian if astigmatism is present) or worse in both eyes in those under age 50 to be considered myopic;
  • Manifest refraction of 1.00 spherical equivalent (as long as there was 1.00D or higher in each meridian if astigmatism is present) or worse in both eyes in those over age 50 to be considered myopic;
  • No history of systemic or ocular disease which might predispose to myopia including premature birth;
  • The index case should have a familial history of myopia in either their parents or children or other close relatives (suggesting a genetic influence);
  • In the event that the parents of the index case have myopia, it is preferred that only one parent be affected with myopia.
  • Some of these bilineal families may be collected if necessary to achieve the desired sample size, but unilateral families are preferred.

You may not qualify if:

  • Excluded from the University of Pennsylvania study are those who have severe diseases that involve myopia, such as Stickler s or Marfan syndromes, ocular disease such as Retinitis Pigmentosa, and those with diseases that may secondarily cause myopia such as diabetes or retinopathy of prematurity. Records of eye examinations obtained prior to the onset of systemic or ocular disease will be accepted.
  • Individuals who complete the Risk Factor Questionnaire and who state that they were born more than a month prematurely will not be included in the study.
  • Individuals who are myopic in one eye and unaffected in the other (ulnilateral myopes) will not be included in the study.
  • Individuals who do not sign the Consent Form will be excluded, and families for whom all necessary members do not sign the Consent Form will be excluded.
  • No fetuses, pregnant women, prisoners or other institutionalized individuals will be enrolled.
  • Generally, myopia itself is not associated with mental impairment, although careful consideration will be given to determining the cognitive understanding of any such potentially impaired person appropriate for enrollment in order to assure that protection of human rights is optimized.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Human Genome Research Institute (NHGRI), 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Young TL, Ronan SM, Drahozal LA, Wildenberg SC, Alvear AB, Oetting WS, Atwood LD, Wilkin DJ, King RA. Evidence that a locus for familial high myopia maps to chromosome 18p. Am J Hum Genet. 1998 Jul;63(1):109-19. doi: 10.1086/301907.

    PMID: 9634508BACKGROUND
  • Young TL, Ronan SM, Alvear AB, Wildenberg SC, Oetting WS, Atwood LD, Wilkin DJ, King RA. A second locus for familial high myopia maps to chromosome 12q. Am J Hum Genet. 1998 Nov;63(5):1419-24. doi: 10.1086/302111.

    PMID: 9792869BACKGROUND
  • Sperduto RD, Seigel D, Roberts J, Rowland M. Prevalence of myopia in the United States. Arch Ophthalmol. 1983 Mar;101(3):405-7. doi: 10.1001/archopht.1983.01040010405011.

    PMID: 6830491BACKGROUND

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Joan Bailey-Wilson, Ph.D.

    National Human Genome Research Institute (NHGRI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2006

First Posted

June 21, 2006

Study Start

April 29, 2002

Primary Completion

March 12, 2020

Study Completion

March 12, 2020

Last Updated

March 13, 2020

Record last verified: 2020-03

Locations